Pfizer pide autorización de emergencia para su vacuna contra el COVID-19
Pfizer Inc y su socio BioNTech SE pidieron a la Administración de Alimentos y Medicamentos (FDA) que permitiera que su vacuna contra el nuevo coronavirus se administrara a personas de alto riesgo en los Estados Unidos. (Fuente: América TV)
- Redacción EC
- 21 de noviembre de 2020 11:01 a.m.
:quality(75)/cdn.jwplayer.com/v2/media/YCYs8mQ4/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/K2VXBO07/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Hr360ko0/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9aBNV21w/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/1mmQymtX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/uWT71yu1/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/slvC7aZb/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/cGeOgJSZ/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/J8IbtDij/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/l3wTKjrg/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/rtAaOHgg/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/cyqKC04q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/hG2Tfg9i/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/MvCWAtLs/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/AHXGnQd5/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/mPidodBK/poster.jpg)